Madeleine Williams
Stock Analyst at Canaccord Genuity
(0.69)
# 4,000
Out of 4,575 analysts
81
Total ratings
38.8%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by Madeleine Williams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: MSB Mesoblast Limited | Maintained: Buy | $3.23 | $2.14 | +50.93% | 5 | Jul 9, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.15 | $0.02 | +581.82% | 9 | Jul 8, 2026 | |
| ASX: MYX Mayne Pharma Group Limited | Maintained: Buy | $6.10 → $3.83 | $2.63 | +45.63% | 3 | Jul 5, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Maintained: Buy | $2.28 | $2.00 | +14.00% | 7 | Jul 4, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $24.00 | $16.70 | +43.71% | 6 | Jun 29, 2026 | |
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.15 | $2.48 | +27.02% | 5 | Jun 11, 2026 | |
| ASX: ATH Alterity Therapeutics Limited | Maintained: Buy | $0.95 | $0.57 | +68.14% | 4 | Jun 10, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.84 | $1.70 | +67.55% | 3 | Jun 6, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $8.41 | $2.23 | +277.13% | 11 | May 26, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $2.27 | $0.25 | +826.53% | 11 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180.82 → $168.62 | $162.24 | +3.93% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.80 → $0.27 | $0.29 | -6.90% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.14 | $0.02 | +566.67% | 5 | May 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.27 → $0.40 | $0.05 | +733.33% | 3 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.84 → $27.90 | $9.81 | +184.40% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.33 → $27.41 | $14.28 | +91.95% | 2 | Oct 15, 2025 |
Mesoblast Limited
Jul 9, 2026
Maintained: Buy
Price Target: $3.23
Current: $2.14
Upside: +50.93%
Syntara Limited
Jul 8, 2026
Maintained: Buy
Price Target: $0.15
Current: $0.02
Upside: +581.82%
Mayne Pharma Group Limited
Jul 5, 2026
Maintained: Buy
Price Target: $6.10 → $3.83
Current: $2.63
Upside: +45.63%
Imricor Medical Systems, Inc.
Jul 4, 2026
Maintained: Buy
Price Target: $2.28
Current: $2.00
Upside: +14.00%
Neuren Pharmaceuticals Limited
Jun 29, 2026
Maintained: Buy
Price Target: $24.00
Current: $16.70
Upside: +43.71%
Cogstate Limited
Jun 11, 2026
Maintained: Buy
Price Target: $3.15
Current: $2.48
Upside: +27.02%
Alterity Therapeutics Limited
Jun 10, 2026
Maintained: Buy
Price Target: $0.95
Current: $0.57
Upside: +68.14%
PYC Therapeutics Limited
Jun 6, 2026
Maintained: Buy
Price Target: $2.84
Current: $1.70
Upside: +67.55%
Clarity Pharmaceuticals Ltd
May 26, 2026
Maintained: Buy
Price Target: $8.41
Current: $2.23
Upside: +277.13%
EBR Systems, Inc.
May 20, 2026
Maintained: Buy
Price Target: $2.27
Current: $0.25
Upside: +826.53%
May 12, 2026
Maintained: Buy
Price Target: $180.82 → $168.62
Current: $162.24
Upside: +3.93%
May 12, 2026
Downgraded: Hold
Price Target: $0.80 → $0.27
Current: $0.29
Upside: -6.90%
May 3, 2026
Maintained: Buy
Price Target: $0.14
Current: $0.02
Upside: +566.67%
Mar 13, 2026
Maintained: Buy
Price Target: $1.27 → $0.40
Current: $0.05
Upside: +733.33%
Mar 2, 2026
Maintained: Buy
Price Target: $32.84 → $27.90
Current: $9.81
Upside: +184.40%
Oct 15, 2025
Maintained: Buy
Price Target: $27.33 → $27.41
Current: $14.28
Upside: +91.95%